Tadashi Matsumoto
Oprichter bij ReqMed Co., Ltd.
Actieve functies van Tadashi Matsumoto
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ReqMed Co., Ltd.
 ReqMed Co., Ltd. Pharmaceuticals: MajorHealth Technology ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| Oprichter | 12-05-1998 | - | |
| President | 12-05-1998 | - | |
| Kihara Memorial Yokohama Foundation For The Advancement | Directeur/Bestuurslid | 01-01-2010 | - |
| Japan Ministry of Economy, Trade & Industry | Corporate Officer/Principal | 01-01-2009 | - |
Loopbaan van Tadashi Matsumoto
Eerdere bekende functies van Tadashi Matsumoto
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TELLA, INC. | Directeur/Bestuurslid | 01-03-2017 | 27-03-2019 |
| ReqMed Research, Inc. | Algemeen Directeur | 01-01-1999 | - |
Opleiding van Tadashi Matsumoto
| University of Tokyo | Undergraduate Degree |
| University of Tsukuba | Masters Business Admin |
Statistieken
Internationaal
| Japan | 7 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
ReqMed Co., Ltd.
ReqMed Co., Ltd. Pharmaceuticals: MajorHealth Technology ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan. | Health Technology |
| ReqMed Research, Inc. | |
| Kihara Memorial Yokohama Foundation For The Advancement | |
| Japan Ministry of Economy, Trade & Industry | Government |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Beurs
- Insiders
- Tadashi Matsumoto
- Ervaring
